Caris Life Sciences, Inc. Common Stock (49J)
FSX
27.20
+2.00 (+7.94%)
Real-time Data
06:00 AM
Day's Range
27.0027.20
52 wk Range
12.3028.40
Financial Statements - 49J - Caris Life Sciences, Inc. Common Stock
Revenue
812.03M▲ 97.0%
Net Income
-68.08M▲ 75.8%Net Margin -8.4%
EBITDA
83.56M▲ 141.5%
Free Cash Flow
66.89M▲ 126.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Sales | 812.03M | 412.26M | 306.12M |
| Cost of Goods | 272.86M | 233.47M | 216.81M |
| Gross Profit | 539.16M | 178.78M | 89.31M |
 Operating Expense | - | - | - |
| Operating Income | 45.11M | -257.12M | -319.55M |
| Non-Operating Interest | - | - | - |
| Other Income Expense | -72.84M | 18.13M | -1.51M |
| Pre Tax Income | -68.08M | -281.89M | -341.41M |
| Income Tax | 0 | 0 | 0 |
| Net Income | -68.08M | -281.89M | -341.41M |
| EPS Basic | -3.22 | -2.7 | -1.816234 |
| EPS Diluted | -3.22 | -2.7 | -1.816234 |
| Basic Shares Outstanding | 167.20M | 254.66M | 254.66M |
| Diluted Shares Outstanding | 167.20M | 254.66M | 254.66M |
| Ebit | -11.23M | -231.86M | -309.80M |
| Ebitda | 83.56M | -201.43M | -260.98M |
| Net Income Continuous Operations | -68.08M | -281.89M | -341.41M |
| Minority Interests | - | - | - |
| Preferred Stock Dividends | 85.43M | 22.06M | 121.11M |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
